GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » EV-to-EBITDA

Qol Holdings Co (TSE:3034) EV-to-EBITDA : 6.80 (As of May. 17, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Qol Holdings Co's enterprise value is 円62,238 Mil. Qol Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円9,147 Mil. Therefore, Qol Holdings Co's EV-to-EBITDA for today is 6.80.

The historical rank and industry rank for Qol Holdings Co's EV-to-EBITDA or its related term are showing as below:

TSE:3034' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.15   Med: 9.36   Max: 17.19
Current: 6.81

During the past 13 years, the highest EV-to-EBITDA of Qol Holdings Co was 17.19. The lowest was 4.15. And the median was 9.36.

TSE:3034's EV-to-EBITDA is ranked better than
80.56% of 463 companies
in the Healthcare Providers & Services industry
Industry Median: 12.87 vs TSE:3034: 6.81

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Qol Holdings Co's stock price is 円1501.00. Qol Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円141.726. Therefore, Qol Holdings Co's PE Ratio for today is 10.59.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Qol Holdings Co EV-to-EBITDA Historical Data

The historical data trend for Qol Holdings Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qol Holdings Co EV-to-EBITDA Chart

Qol Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.89 5.42 5.80 3.42 3.24

Qol Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.30 3.24 6.64 8.42 7.44

Competitive Comparison of Qol Holdings Co's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Qol Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qol Holdings Co's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Qol Holdings Co's EV-to-EBITDA falls into.



Qol Holdings Co EV-to-EBITDA Calculation

Qol Holdings Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=62238.436/9147
=6.80

Qol Holdings Co's current Enterprise Value is 円62,238 Mil.
Qol Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円9,147 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qol Holdings Co  (TSE:3034) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Qol Holdings Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1501.00/141.726
=10.59

Qol Holdings Co's share price for today is 円1501.00.
Qol Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円141.726.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Qol Holdings Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Qol Holdings Co (TSE:3034) Business Description

Traded in Other Exchanges
N/A
Address
4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines